EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Unveiling Pharmacogenomic Patterns in Breast Cancer Through Big Data

Huiyi Yang, Joseph Finkelstein

Studies in Health Technology and Informatics · 2025

DOI: 10.3233/shti251005 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Studies in Health Technology and Informatics, 2025. Verfasst von Huiyi Yang und 1 weiteren Autor:innen. Beteiligte Einrichtung: University of Utah. Hauptthemen laut MEDLINE: Breast Neoplasms, Cytochrome P-450 CYP2D6, Pharmacogenetics, Big Data. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Pharmacogenomics (PGx) is pivotal in personalized medicine, particularly in cancer care, where drug efficacy and toxicity often vary with genetic variability. This study investigates the prevalence of CYP2D6-related medications and phenotypes in a cohort of 5,576 female breast cancer patients using genomic and electronic health record (EHR) data from the NIH’s All of Us Research Program. A total of 77% of patients were prescribed at least one CYP2D6 metabolized drug. A customized pipeline was developed to determine CYP2D6 genotypes and phenotypes, identifying actionable phenotypes in 12.5% of patients. The prevalence of CYP2D6-associated drugs, including Tamoxifen, ondansetron, and tramadol, were widely prescribed and increased significantly following cancer diagnosis. Approximately 25% of phenotyped patients exhibited non-normal metabolizer types, emphasizing the importance of pharmacogenomic considerations in clinical decision-making. These findings emphasize the potential of incorporating PGx guidelines into routine clinical practice to optimize breast cancer treatment and improve patient outcomes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast NeoplasmsCytochrome P-450 CYP2D6PharmacogeneticsBig DataAntineoplastic AgentsHumansFemaleElectronic Health RecordsPrecision MedicineMiddle AgedPhenotypeAgedGenotype

Stichwörter der Autor:innen

Breast CancerCYP2D6Pharmacogenomics (PGx)Tamoxifen

Substanzen

Cytochrome P-450 CYP2D6Antineoplastic Agents

Autor:innen und Institutionen

  • University of Utah.

Zitieren

APA

Yang, H., & Finkelstein, J. (2025). Unveiling Pharmacogenomic Patterns in Breast Cancer Through Big Data. Studies in Health Technology and Informatics. https://doi.org/10.3233/shti251005

Vancouver

Yang H, Finkelstein J. Unveiling Pharmacogenomic Patterns in Breast Cancer Through Big Data. Studies in Health Technology and Informatics. 2025. doi:10.3233/shti251005

BibTeX
@article{Yang2025,
  author = {Yang, Huiyi and Finkelstein, Joseph},
  title = {Unveiling Pharmacogenomic Patterns in Breast Cancer Through Big Data},
  journal = {Studies in Health Technology and Informatics},
  year = {2025},
  doi = {10.3233/shti251005}
}
Kostenlos starten →